Back

Procedural safety and mid-term outcomes after valve-in-valve transcatheter aortic valve implantation: a prospective single-center study

19 February 2026 (08:00 - 18:30)
Organised by: Logo
Congress Presentation Part of: Optimal management of implanted bioprosthesis Intervention EAPCI Premium Access EAPCI Summit 2026 European Association of Percutaneous Cardiovascular Interventions (EAPCI)

About the speaker

Photo
Doctor Georgios Papadopoulos

Interbalkan Medical Center, Thessaloniki (Greece)

7 More presentations in this session

Presentation thumbnail
Biological remodeling and integration of TAVI bioprostheses across distinct anatomical zones and their correlation with hemodynamic outcomes at 180 days
Professor P. Buszman (Katowice, PL)
Abstract Slides
Presentation thumbnail
Conservative versus surgical treatment of patients with infective endocarditis after transcatheter aortic valve implantation: a systematic review and meta-analysis
Doctor N. Pyrpyris (Athens, GR)
Abstract Slides
Presentation thumbnail
Evaluation of transcatheter aortic valve frame expansion and geometry using intravascular ultrasound
Doctor Y. Willemen (Copenhagen, DK)
Abstract Slides
Presentation thumbnail
Sex differences in characteristics and outcomes after TAVR-in-TAVR: the PANDORA international registry
Doctor A. Popolo Rubbio (San Donato Milanese, IT)
Abstract Slides
Presentation thumbnail
Leaflet modification using a simplified unicorn technique for TAVI with self-expanding platforms in degenerated bioprosthetic valves
Mr N. Azzola Guicciardi (Milan, IT) Doctor A. Beneduce (Milan, IT)
Abstract Slides

Access the full session

Session thumbnail
Optimal management of implanted bioprosthesis

The Event

Event poster

EAPCI Summit 2026

19 February - 20 February 2026

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources